BDE-47 and BDE-209 inhibit proliferation of Neuro-2a cells via inducing G1-phase arrest

Publication date: Available online 21 December 2016 Source:Environmental Toxicology and Pharmacology Author(s): Hongmei Chen, Xuexi Tang, Bin Zhou, Ningning Xu, Zhongyuan Zhou, Kuan Fang, You Wang Cell proliferation is closely related to cell cycle which is strictly regulated by genes and regulatory proteins. In the present study, we comparatively analyzed the toxic effects of BDE-47 and BDE-209 on cell proliferation of Neuro-2a cells, and the possible mechanism was discussed. The results indicated that BDE-47 significantly inhibited the cell proliferation and the cell cycle were arrest at G1 phase, while BDE-209 had little effects on either cell proliferation or cell cycle. qRT-PCR and Western blot assay presented that BDE-47 up-regulated the gene expressions of p53 and p21, which down-regulated the expresseion of cyclinD1 and CDK2, and inhibited retinoblastoma protein (pRb) phosphorylation. This process could effectively arrest the cell cycle at G1 phase, which finally caused the inhibition on Neuro-2a cell proliferation. However, BDE-209 was only up-regulated the gene expressions of p53, also suggested to be involved in the inhibition on Neuro-2a cell proliferation.
Source: Environmental Toxicology and Pharmacology - Category: Environmental Health Source Type: research

Related Links:

AbstractWe sought to develop an immunohistochemical (IHC) tool to support the diagnosis of parathyroid carcinoma (PC) and help differentiate it from atypical parathyroid neoplasms (atypical) and benign adenomas. Distinguishing PC from benign parathyroid neoplasms can be challenging. Many cases of PC are histopathologically borderline for definitive malignancy. Recently, individual IHC biomarkers have been evaluated to aid in discrimination between parathyroid neoplasms. PC, atypical parathyroid neoplasms, and parathyroid adenomas treated at our institution from 1997 to 2014 were studied retrospectively. IHC analysis was pe...
Source: Endocrine Pathology - Category: Pathology Source Type: research
Conditions:   Retinoblastoma;   Secondary Primary Malignancies After Retinoblastoma Intervention:   Other: blood draw Sponsors:   VU University Medical Center;   University Hospital, Essen;   Institut Curie;   Ligue contre le cancer, France Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The expression patterns and functional roles of miRNAs in retinoblastoma (RB) are poorly understood, especially those involved in chemoresistance. Here, we validated the expression pattern of 20 potential RB-suppressive miRNAs and confirmed that miR-184 is the most significantly decreased miRNA in human RB tissues, as well as chemoresistant cell line. Bioinformatic and molecular analyses revealed that SLC7A5 has three binding sites of miR-184 and significantly increased in RB tissues. miR-184 negatively correlated with SLC7A5 expression in RB tissues and mainly target position 2494-2513 of the SLC7A5 3′UTR to inhibit...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
This case report describes a 17-month-old girl with group B retinoblastoma treated with cycles of chemotherapy.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research
Retinoblastoma (Rb) is the most common ocular pediatric malignancy that arises from the retina and is caused by a mutation of the two alleles of the tumor suppressor gene, RB1. Although early detection provides the opportunity of controlling the primary tumor with effective therapies, metastatic activity is fatal. Non-coding RNAs (ncRNAs) have emerged as important modifiers of a plethora of biological mechanisms including those involved in cancer. They are classified into short and long ncRNAs according to their length. Deregulation of all these molecules has also been shown to play a critical role in Rb pathogenesis and p...
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
Cell Death &Disease, Published online: 13 November 2019; doi:10.1038/s41419-019-2084-1Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6
Source: Cell death and disease - Category: Internal Medicine Authors: Source Type: research
In conclusion, homozygous CDKN2A deletion is rare and could be used to predict response to CDK4/6 inhibitors in association with other genomic features. We encourage further trials in this direction. PMID: 31709901 [PubMed - as supplied by publisher]
Source: Cancer Biology and Therapy - Category: Cancer & Oncology Authors: Tags: Cancer Biol Ther Source Type: research
This study suggests that adult retinoblastoma survivors treated with enucleation continue to struggle with a unique set of psychosocial problems. Future interventions can be designed to teach survivors more active coping skills (e.g., for appearance-related issues, vision-related issues, and teasing/bullying) to optimize survivors' long-term quality of life. PMID: 31699178 [PubMed - as supplied by publisher]
Source: Palliative and Supportive Care - Category: Palliative Care Authors: Tags: Palliat Support Care Source Type: research
DNA and Cell Biology, Ahead of Print.
Source: DNA and Cell Biology - Category: Cytology Authors: Source Type: research
Condition:   Retinoblastoma Intervention:   Drug: Episcleral Topotecan Sponsor:   Targeted Therapy Technologies, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Drugs & Pharmacology | Environmental Health | Eye Cancers | Genetics | Neurology | Retinoblastoma | Study | Toxicology